Penicimides A and B, two novel diels–alder [4 + 2] cycloaddition ergosteroids from Penicillium herquei

[Display omitted] •Sixteen ergosteroids including five ones were isolated.•Penicimides A and B are novel naturally occurring [4 + 2] Diels–Alder cycloaddition.•3 displayed significant anti-inflammatory activity in LPS-induced RAW264.7 cells.•Plausible biosynthetic pathways of compounds 1–6 were prop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic chemistry 2024-02, Vol.143, p.107025-107025, Article 107025
Hauptverfasser: Deng, Mengyi, Xiao, Yan, Wang, Shu, Zhang, Min, Qiao, Yuben, Huang, Shuai, Xie, Jiang, Zhou, Xianli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Sixteen ergosteroids including five ones were isolated.•Penicimides A and B are novel naturally occurring [4 + 2] Diels–Alder cycloaddition.•3 displayed significant anti-inflammatory activity in LPS-induced RAW264.7 cells.•Plausible biosynthetic pathways of compounds 1–6 were proposed.•The structure–activity relationship of the isolates was summarized. Two novel naturally occurring [4 + 2] Diels–Alder cycloaddition ergosteroids (1 and 2), three undescribed oxidized ergosteroids (3–5), and eleven known analogs (6–16) were isolated from Penicillium herquei. Compounds 1 and 2 represent the first reported cycloadducts of a steroid with 1,4,6-trimethyl-1,6-dihydropyridine-2,5-dione or 4,6-dimethyl-1,6-dihydropyridine-2,5-dione to date. Compound 3 is the C-15 epimer of (22E,24R)-9α,11β-dihydroxyergosta-4,6,8(14),22-tetraen-3-one (14). The chemical structures of these compounds were elucidated through widespread spectroscopic analyses, mainly including HRESIMS and 1D and 2D NMR data, calculated 13C NMR-DP4+ analysis, and electronic circular dichroism (ECD) data analyses. Biological evaluations of Compounds 1–16 revealed that 3, 9–11, and 15 inhibited the production of NO in LPS-induced RAW264.7 cells with an IC50 value from 7.37 ± 0.69 to 38.9 ± 2.25 μM (the positive control dexamethasone IC50: 9.54 ± 0.71 μM). In addition, Compound 3 exhibited a potent inhibitory effect on the secretion of the proinflammatory cytokines TNF-α and IL-6, the transcription level of the proinflammatory macrophage markers TNF-α, and the expression of the iNOS protein.
ISSN:0045-2068
1090-2120
DOI:10.1016/j.bioorg.2023.107025